We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Autoimmune diseases

News List

Calypso Biotech BV Secures 20 Million EUR in Series A Financing and Strengthens Team to Develop Anti-IL-15 Therapeutic Antibody for Autoimmune Diseases b3cnewswire
February 21, 2019
Calypso Biotech, an emerging leader in the development of therapeutic antibodies for autoimmune diseases, announces today the closing of a €20M Series A financing co-led by Gilde Healthcare and Inkef Capital.....
Catalyst's long-delayed Firdapse snags FDA nod, but pricing questions loom fiercepharma
December 05, 2018
It took a breakthrough designation, orphan drug status, an embarrassing up-front rejection letter and some extra trials, but Catalyst Pharmaceuticals has finally crossed the finish line with Firdapse.
Which of the Blockbuster Drugs on the Autoimmune Drug Market Will Show the Glory that Humira Had?(3) Siyi
June 08, 2018
Among other autoimmune diseases, anti-IL-12/23 Stelara does not have advantages over TNFα inhibitors...
BMS's Orencia receives FDA approval for treatment of active psoriatic arthritis in adults cphi-online
July 13, 2017
Orencia now approved in three autoimmune diseases.
Regen BioPharma sees success in Its pre-clinical small molecule optimization program for NR2F6 cphi-online
April 14, 2017
The company's small molecule drug program is aimed at treating cancer and autoimmune diseases.

Previous page 1 2 Next page